<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org">
<channel>
<title>Daily Pharmaceuticals industry news in North America</title>
<link>https://www.bizcommunity.com/450/398.html</link>
<description>North America Pharmaceuticals news</description>
<ttl>15</ttl>
<category>Pharmaceuticals news - North America</category>
<image>
<url>https://www.bizcommunity.com/res/img/logo.gif</url>
<title>Daily Pharmaceuticals industry news in North America</title>
<link>https://www.bizcommunity.com/450/398.html</link>
</image>
<language>en-us</language>
<pubDate>Mon, 06 Apr 2026 14:56:49 +0200</pubDate>
<item>
	<title>Abbott's uninterrupted streak: 398th consecutive quarterly dividend declared</title>
	<link>https://www.bizcommunity.com/Article/1/148/239496.html</link>
	<description>The board of directors of Abbott  Laboratories (Pty) Ltd recently declared a quarterly common dividend of USD 51 cents per share.</description>
	<media:content url="https://biz-file.com/c/2306/703008.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2306/703008.jpg?5" length="65011" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2306/703008.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-239496</guid>
	<pubDate>Thu, 22 Jun 2023 12:56:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>Johnson &amp; Johnson to stop sale of talcum baby powder globally</title>
	<link>https://www.bizcommunity.com/Article/1/162/230542.html</link>
	<description>Talc-based Johnson's Baby Powder will be discontinued globally in 2023, as Johnson &amp; Johnson transitions its baby powder portfolio to cornstarch.</description>
	<media:content url="https://biz-file.com/c/2208/666208.jpg?3" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2208/666208.jpg?3" length="75177" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2208/666208.jpg?3" width="240" height="135" />
	<guid isPermaLink="false">1-230542</guid>
	<pubDate>Mon, 15 Aug 2022 09:30:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>GlaxoSmithKline rejects Unilever's £50bn bid for consumer health unit</title>
	<link>https://www.bizcommunity.com/Article/1/784/224090.html</link>
	<description>GlaxoSmithKline (GSK), the owner of Aquafresh, Voltaren and Eno, has rejected a proposal from Unilever to acquire GSK's Consumer Healthcare business for a total acquisition value of £50bn, comprising £41.7bn in cash and £8.3bn in Unilever shares.</description>
	<media:content url="https://biz-file.com/c/2201/642093-1200x673.jpg?2" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2201/642093-1200x673.jpg?2" length="54521" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2201/642093.jpg?2" width="240" height="135" />
	<guid isPermaLink="false">1-224090</guid>
	<pubDate>Mon, 17 Jan 2022 08:46:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>New global drug policy index finds most countries fail drug policy</title>
	<link>https://www.bizcommunity.com/Article/1/398/221860.html</link>
	<description>The drug policy median score across all 30 countries for humane and health driven drug policies is just 48/100, with Norway, despite topping the inaugural edition of the Global Drug Policy Index, still only managing a score of 74/100. The other four leading countries are New Zealand, Portugal, the UK and Australia, with Brazil, Uganda, Indonesia, Kenya, and Mexico the five lowest-ranking countries.</description>
	<media:content url="https://biz-file.com/c/2111/634338.jpg?1" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2111/634338.jpg?1" length="41503" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2111/634338.jpg?1" width="240" height="135" />
	<guid isPermaLink="false">1-221860</guid>
	<pubDate>Mon, 08 Nov 2021 06:44:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>Pharmaceutical companies collaborate against climate change</title>
	<link>https://www.bizcommunity.com/Article/1/398/221848.html</link>
	<description>The Energize programme, a collaboration between 10 global pharmaceutical companies to engage hundreds of suppliers in climate action and decarbonisation of the pharmaceutical value chain, has been announced today - on Energy Day of the 2021 United Nations Conference of Parties (COP26) on climate change.</description>
	<media:content url="https://biz-file.com/c/2111/634312.jpg?1" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2111/634312.jpg?1" length="49806" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2111/634312.jpg?1" width="240" height="135" />
	<guid isPermaLink="false">1-221848</guid>
	<pubDate>Fri, 05 Nov 2021 14:42:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>Good quality medical transcription is achievable</title>
	<link>https://www.bizcommunity.com/Article/224/398/127829.html</link>
	<description>Medicine is one of the noblest fields; mainly due to its major role as life-saver. This has resulted as a boom in the health-care industry in the past few decades.</description>
	<media:thumbnail url="https://biz-file.com/c/1505/276981.jpg" width="240" height="135" />
	<guid isPermaLink="false">1-127829</guid>
	<pubDate>Tue, 05 May 2015 08:26:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>Google sets up anti-ageing platform</title>
	<link>https://www.bizcommunity.com/Article/224/544/117456.html</link>
	<description>SAN FRANCISCO, USA: Google's new company aimed at addressing problems of health and ageing has taken a step forward with its own website and mission statement.</description>
	<media:thumbnail url="https://biz-file.com/c/1408/218963.jpg" width="240" height="135" />
	<guid isPermaLink="false">1-117456</guid>
	<pubDate>Wed, 13 Aug 2014 10:20:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>Google sets $250m aside to stop illegal online pharmacies</title>
	<link>https://www.bizcommunity.com/Article/224/544/117342.html</link>
	<description>SAN FRANCISCO, USA: Google has agreed in a court settlement to spend at least $250m over the next five years to help fight illegal online pharmacies selling medicines to US customers.</description>
	<media:thumbnail url="https://biz-file.com/c/1408/218330.jpg" width="240" height="135" />
	<guid isPermaLink="false">1-117342</guid>
	<pubDate>Mon, 11 Aug 2014 10:11:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>App provides prompt delivery of dagga order</title>
	<link>https://www.bizcommunity.com/Article/224/542/116916.html</link>
	<description>SAN FRANCISCO, USA:- Startup company Eaze has released a smartphone application promising prompt, professional delivery of medical marijuana to the doors of patients in San Francisco.</description>
	<media:thumbnail url="https://biz-file.com/c/1407/216064.jpg" width="240" height="135" />
	<guid isPermaLink="false">1-116916</guid>
	<pubDate>Thu, 31 Jul 2014 11:26:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
<item>
	<title>Valeant's higher offer rejected by Allergan again</title>
	<link>https://www.bizcommunity.com/Article/224/516/114619.html</link>
	<description>NEW YORK, USA: Botox manufacturer Allergan has rejected, for a third time, a takeover bid from Canadian drugs maker Valeant, claiming the increased offer still substantially under-values the company.</description>
	<media:thumbnail url="https://biz-file.com/c/1406/203788.jpg" width="240" height="135" />
	<guid isPermaLink="false">1-114619</guid>
	<pubDate>Wed, 11 Jun 2014 06:53:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/450/398.html">Bizcommunity Pharmaceuticals North America</source>
</item>
</channel>
</rss>